https://fdawatch.net/2026/10/12/an-evolving-direction-for-drug-oversight/FDA Watch Podcasten2026-10-12T14:35:59+00:00An Evolving Direction for Drug OversightFDA, regulation, FDA Watch, new episode, pharmaceuticals, AI, artificial intelligence, health, healthcare, commissioner, drug development, drugs, pharma, animal testing, innovation, biologics, generic drugs, leadership, biotech, Brian Malkin, Spencer Fane, NAM, skinny labeling, Heidi Overton, creativityhttps://fdawatch.net/wp-content/uploads/2025/08/fdawatch_artworkupdated8.5.jpg?w=150